Autistic Disorder Clinical Trial
Official title:
Improving Social Cognition for Adults With Autism Spectrum Disorder by the Serious Game JeStiMulE Versus Classic Video Game Stimulation Not Improving Social Cognition
Verified date | July 2018 |
Source | Fondation Lenval |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The serious game "JeStiMulE" (Educational Game for Multisensory Stimulation of Children with
developmental disorders), developed by the Autism Resources Center of Nice, was created to
teach social cognition including emotion recognition in context, for children and adolescents
with autism. In a previous study, JeStiMulE has demonstrated efficacy in a population of
young people aged 6-17 years old with high and low levels of autism.
According to the recommendations of the 2011 HAS, disorders of social interactions are the
most persistent troubles of the autistic triad in life.
It seems essential to us to be able to offer young adults with autism, rehabilitation methods
adapted to their trouble, and to observe whether JeStiMulE could be one of them.
This study researches the effectiveness of the serious game JeStiMulE in the improvement
social cognition for adults with autism versus controls.
The main goal is:
- Comparing the improvement in social cognition among adults with autism using the serious
game JeStiMulE or not.
Two groups will be formed: a first one of fifteen adults with a diagnosis of autism
objectified, this group will use JeStiMulE and will be compared to a control group of adults
with autism, using another video game, not aimed to improve social cognition.
The objective of JeStiMulE players will be ending the game after a learning period and two
playing periods (with emotional words and idioms, including three modules each). The groups
will be matched with their nonverbal IQ through Raven matrices and visual memory tasks
(WAIS).
The control group will also be stimulated through a video game, not specialized in improving
social cognition.
The primary outcome will be assessed by the emotion recognition at the FEEST of Ekman test:
by the number of emotions recognized on faces, compared to the number of emotion presented
through this test.
The secondary outcomes will be:
- The rest of social cognition improvement by several tests (the theory of mind with the
score of the Tom-15, the intention with the score Sarfati cartoons, empathy with a
self-administered questionnaire: EQ / AQ).
- The impact on the quality of life, verbal fluency of emotional words, and the feedback
from JeStiMulE players will also be seen as a secondary outcome.
Status | Completed |
Enrollment | 30 |
Est. completion date | September 20, 2017 |
Est. primary completion date | September 20, 2016 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 40 Years |
Eligibility |
Inclusion Criteria: - Subjects from 18 to 40 years old. - Diagnosis of autism according to the diagnostic criteria of the DSM 5 - Cognitive level estimated by the matrices of Raven > 6 years amount age - Compatible verbal level with the realization of the neurocognitive tests estimated by the verbal indication of understanding of the WAIS - Legal Subjects or guardian having given their informed consent and written; - Subjects affiliated to the Social Security. Exclusion Criteria: - The subjects with unbalanced epilepsy - The pregnant women |
Country | Name | City | State |
---|---|---|---|
France | Fondation Lenval | Nice | |
France | Hôpital Pasteur - CHU de Nice | Nice | |
France | Hôpital psychiatrique de Sainte marie | Nice |
Lead Sponsor | Collaborator |
---|---|
Fondation Lenval |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change of Emotion recognition | assessed by the emotion recognition at the FEEST of Ekman test: by the number of emotions recognized on faces, compared to the number of emotion presented through this test. | Comparaison at 4 weeks to baseline | |
Secondary | Change of Social cognition | Comparaison at 4 weeks to baseline after playing 6 sessions of one hour of video game Jestimule or control. The rest of social cognition improvement by several tests (the theory of the mind with the score of the Tom-15, the intention with the score Sarfati cartoons, empathy with a self-administered questionnaire: EQ / AQ). |
Comparaison at 4 weeks to baseline | |
Secondary | Change of impact on quality of life | The impact on quality of life will be evaluated by Vineland test | Comparaison at 4 weeks to baseline | |
Secondary | Impact on the verbal fluency of emotional words (number of words emitted perminute) | The verbal fluence is the number of words emitted per minute at a patient speaking describing a full of imagery scene | Comparaison at 4 weeks to baseline | |
Secondary | Feedback from JeStiMulE players | the feedback from JeStiMulE players will be registered with a questionnary | Comparaison at 4 weeks to baseline |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03222375 -
SQUEDâ„¢ Series 28.1 Home-use and Treatment of Autowave Reverberator of Autism
|
N/A | |
Completed |
NCT02708290 -
Mental Imagery Therapy for Autism (MITA) - an Early Intervention Computerized Language Training Program for Children With ASD
|
||
Completed |
NCT02369445 -
Investigation of Teacher-Mediated Toilet Training Using a Manualized Moisture Alarm Intervention
|
N/A | |
Completed |
NCT01617460 -
A Long-term, Extended Treatment Study of Aripiprazole in Pediatric Patients With Autistic Disorder
|
Phase 3 | |
Completed |
NCT01592747 -
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
|
Phase 2 | |
Completed |
NCT01400269 -
An Evaluation of a Developmentally-Based Parent Training Program for Children With Autism
|
N/A | |
Active, not recruiting |
NCT02442115 -
Impact of Improving GI Symptoms on Autism Symptoms and Oxidative Stress
|
||
Completed |
NCT00926471 -
Social Skills and Anxiety Reduction Treatment for Children and Adolescents With Autism Spectrum Disorders
|
Phase 1 | |
Completed |
NCT00365859 -
Study of Aripiprazole in the Treatment of Serious Behavioral Problems in Children and Adolescents With Autistic Disorder (AD)
|
Phase 3 | |
Completed |
NCT00692315 -
Treating Oxidative Stress in Children With Autism
|
N/A | |
Completed |
NCT00198107 -
Evaluating the Effectiveness of Aripiprazole and D-Cycloserine to Treat Symptoms Associated With Autism
|
Phase 3 | |
Completed |
NCT00095420 -
Relationship Training for Children With Autism and Their Peers
|
N/A | |
Completed |
NCT00027404 -
Study of Fluoxetine in Adults With Autistic Disorder
|
N/A | |
Recruiting |
NCT05910502 -
Project AFECT (Autism Family Empowerment Coaching and Training Program)
|
N/A | |
Completed |
NCT04820998 -
Living in a Precarious Situation With an Autistic Child: What Are the Issues at Stake for Support in Care
|
||
Withdrawn |
NCT05413187 -
A Trial to Assess the Efficacy and Safety of Medical Grade Cannabis in Children Diagnosed With Autism Spectrum Disorder
|
Phase 2 | |
Recruiting |
NCT02275455 -
Design Of WELL Being Monitoring Systems, Application in Autism
|
N/A | |
Completed |
NCT02766101 -
Manville Moves: an Exercise Intervention for Behavioral Regulation Among Children With Behavioral Health Challenges
|
N/A | |
Completed |
NCT01977248 -
Sensorimotor Affect Relationship-based Therapy (SMART) for Children With Autism Spectrum Disorders Ages 2-12
|
N/A | |
Terminated |
NCT01592773 -
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
|
Phase 2 |